|
|
|
Volumn 52, Issue 6, 1999, Pages 489-490
|
|
Clinical and bacteriological effects of cefetamet pivoxil against community-acquired respiratory tract infections. Part III
a a b b b b b |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
BETA LACTAMASE;
CEFETAMET;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
BRONCHITIS;
COMMUNICABLE DISEASE;
DRUG INHIBITION;
HAEMOPHILUS INFLUENZAE;
HUMAN;
LARYNGITIS;
MAJOR CLINICAL STUDY;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
OUTPATIENT;
PHARYNGITIS;
RESPIRATORY TRACT INFECTION;
STREPTOCOCCUS PYOGENES;
TONSILLITIS;
ADULT;
AGED;
BACTERIA;
CEFTIZOXIME;
COMMUNITY-ACQUIRED INFECTIONS;
DRUG RESISTANCE, MICROBIAL;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
RESPIRATORY TRACT INFECTIONS;
|
|
EID: 0032778969
PISSN: 03682781
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (11)
|
